Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Nov 28, 2020 5:24pm
214 Views
Post# 31995469

RE:RE:RE:RE:RE:New warrants at 1.10

RE:RE:RE:RE:RE:New warrants at 1.10

you are right 8 warrants for 1 share at a strike price of .09 each but unless you were given the warrants at the offering you have to buy them now at .075 each, hence the .165. You are talking down to people about not knowing and stick to buying shares, but you don't seem to understand how it works.




LionWhisperer wrote: No you are talking about two sets of warrants.First ones that are trading now are 8 warrants strike price of 72 cents

Effective today, warrants issued by the company, including its TSX-listed warrants, have also been adjusted proportionately in response to the consolidation. On Sept. 18, 2020, the exercise of eight listed warrants will be required to purchase one postconsolidation common share for an aggregate exercise price of 72 cents per whole common share. The listed warrants continue to trade under their existing Cusip.

Each Unit consists of one common share in the capital of the Company (a “Common Share”, and each Common Share comprising part of a Unit, an “Offered Share”) and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one Common Share (a “Warrant Share”) at an exercise price of $1.10 per Warrant Share, subject to adjustment in certain circumstances, at any time prior to 5:00 p.m. (Toronto time) on the date that is thirty-six (36) months following the first Closing
The next warrants are set at 


 

<< Previous
Bullboard Posts
Next >>